Viking Therapeutics
VKTX
VKTX
144 hedge funds and large institutions have $260M invested in Viking Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.29% more ownership
Funds ownership: 51.73% → 56.03% (+4.3%)
1% more funds holding
Funds holding: 143 → 144 (+1)
Holders
144
Holding in Top 10
–
Calls
$8.57M
Puts
$2.19M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$5.27M | |
| 3 | +$4.58M | |
| 4 |
Two Sigma Advisers
New York
|
+$3.56M |
| 5 |
Citigroup
New York
|
+$2.63M |
Top Sellers
| 1 | -$5.43M | |
| 2 | -$2.21M | |
| 3 | -$1.63M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.22M |
| 5 |
Renaissance Technologies
New York
|
-$1.01M |